Clinical Trials Logo

Clinical Trial Details — Status: Recruiting

Administrative data

NCT number NCT05960448
Other study ID # 1727500
Secondary ID
Status Recruiting
Phase N/A
First received
Last updated
Start date July 30, 2023
Est. completion date July 30, 2026

Study information

Verified date August 2023
Source James J. Peters Veterans Affairs Medical Center
Contact Matthew T Maher, MS
Phone (718) 584-9000
Email Matthew.Maher@va.gov
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

The goal of this interventional crossover study is to determine the effects of transcutaneous spinal cord stimulation (TSCS) on the ability to perform moderate exercise and regulate core body temperature in the chronic spinal cord injury community. The main questions it aims to answer are: - What are the effects of active TSCS targeted for BP control on exercise endurance time and HR recovery during submaximal arm cycle ergometry (ACE) as compared to sham TSCS in participants with chronic, cervical SCI? - What are the effects of active TSCS on Tcore responses to cool ambient exposure and on subjective reporting of thermal comfort and thermal sensitivity as compared to sham TSCS. Participants will receive sham and active stimulation while using an arm bicycle or while in a cold room. Participants are free to participate in either the exercise phase, the cold room phase, or both phases of this study. Please note that there no expected long term benefits of this study.


Description:

The purpose of the first part of this research study is to determine the effects of active transcutaneous spinal cord stimulation (TSCS) targeted for blood pressure (BP) control on exercise endurance time and heart rate (HR) recovery time during an arm cycle test. The results will help guide experimental studies aimed at improving exercise, rehabilitation, health, and longevity in the SCI population. If the participant chooses to participate in part one of this study, the participant will be asked to visit the laboratory for 2 visits that take about 3-4 hours each. The purpose of part two of this study is to compare the effects of electricity being delivered through surface electrodes (sticky pads on the participants skin), called active transcutaneous spinal cord stimulation (TSCS), compared to sham TSCS (sticky pads with electricity initially turned on but then turned off) on the participants ability to 1) keep the participants body temperature stable and 2) feel comfortable, while in a cool environment (cool room at 64° F) for 90 minutes. The investigators will assess the participant thermal sensation by asking the participant if overall they feel cold, cool, neutral, warm, or hot and their comfort level by asking the participant to grade their thermal comfort (how comfortable or how uncomfortable they feel) when the participant is seated in a thermoneutral room (80° F) and again in the cool room with active TSCS compared to the cool room with sham TSCS. The results will help guide experimental studies aimed at improving health and longevity in the population with SCI. If the participant chooses to participate in this study, there will be 2 study visits that last about 3-4 hours each.


Recruitment information / eligibility

Status Recruiting
Enrollment 20
Est. completion date July 30, 2026
Est. primary completion date July 30, 2026
Accepts healthy volunteers No
Gender All
Age group 18 Years and older
Eligibility Inclusion Criteria: - You are above the age of 18 years old - You have an SCI between C3-T6 - You have been injured longer than 1 year - You participated in a prior experiment "Targeted Transcutaneous Spinal Cord Stimulation to Restore Autonomic Cardiovascular Health in Individuals with Spinal Cord Injury" - You have an American Spinal Injury Association injury classification scale (AIS) A, B, C - Your prescription medications have not changed for at least 30 days Exclusion Criteria: - You have a history of seizures - You have an acute illness or infection - You have diabetes - You have untreated thyroid disease - You have a neurological condition other than SCI (Alzheimer's disease, dementia, stroke, multiple sclerosis, Parkinson's disease, etc.) - You have a history of heart or vascular disease (coronary artery disease, congestive heart failure, peripheral artery disease,) - You have a history of moderate or severe head trauma (TBI) or diagnosed with cognitive impairment - You have a present or history of a psychological disorder - You have contraindications to electricity over your spine - You are dependent on a ventilator to breathe or have an open tracheostomy site - You have a recent history of substance abuse (within the past 3 months) - You have open wounds over the spine at the level targeted for stimulation - You are pregnant

Study Design


Intervention

Other:
Transcutaneous Spinal Cord Stimulation (TSCS)
This is electrical stimulation delivered to the spinal cord through the skin and tissue using a cathode electrode to deliver the stimulation and anode electrodes to ground the circuit.
Sham Transcutaneous Spinal Cord Stimulation
This is designed to appear like transcutaneous spinal cord stimulation without actually delivering the stimulation.

Locations

Country Name City State
United States James J Peters VAMC Bronx New York

Sponsors (1)

Lead Sponsor Collaborator
James J. Peters Veterans Affairs Medical Center

Country where clinical trial is conducted

United States, 

Outcome

Type Measure Description Time frame Safety issue
Primary Exercise Endurance Time Total time (minutes) the participant is able to exercise during the submaximal arm cycle ergometry test. During procedures (30 minutes)
Primary Recovery Heart Rate Total time (minutes) for heart rate to return to baseline levels after submaximal exertion. During procedures (60 minutes)
Primary Tcore This outcome measure is measured in degrees Celsius. During procedures (90 minutes)
Primary Thermal Comfort Feeling of comfort from: +3 (very comfortable) to -3 (very uncomfortable). During procedures (90 minutes)
Secondary Workload This outcome is measured in Watts (highest watt obtained) End of exercise (30 minutes)
Secondary Rate of Perceived Exhaustion This is measured on the Borg scale (06-20) higher number = harder perceived exertion End of exercise (30 minutes)
See also
  Status Clinical Trial Phase
Completed NCT02705755 - TD-9855 Phase 2 in Neurogenic Orthostatic Hypotension (nOH) Phase 2
Recruiting NCT05941819 - ARC Therapy to Restore Hemodynamic Stability and Trunk Control in People With Spinal Cord Injury N/A
Completed NCT05529147 - The Effects of Medication Induced Blood Pressure Reduction on Cerebral Hemodynamics in Hypertensive Frail Elderly
Recruiting NCT02897063 - Effects of Midodrine and Droxidopa on Splanchnic Capacitance in Autonomic Failure Phase 1
Completed NCT02726776 - Suspension Syndrome N/A
Completed NCT01559675 - Trial Comparing Low Dose and High Dose Steroids in Patients Undergoing Colorectal Surgery N/A
Not yet recruiting NCT04440085 - RaGuS Trial by Postoperative Patients Phase 4
Recruiting NCT03732716 - Sarcopenia and Orthostatic Hypotension
Recruiting NCT05621460 - The Effect of Water Carbonation on Orthostatic Tolerance N/A
Completed NCT02632318 - Dawn Simulation and Postural Hypotension Phase 4
Completed NCT05729724 - Effect of Pharmacological Interventions on Systolic Blood Pressure Drops (SynABPM 2 Proof-of-concept)
Completed NCT03721393 - Data Collection - Of Syncope Tilt Table Testing Study
Completed NCT01030874 - Orthostatic Hypotension Treatment on Rehab Unit N/A
Completed NCT01223391 - Abdominal Compression in Orthostatic Hypotension N/A
Completed NCT01362751 - Orthostatic Hypotension in Elderly Nursing Home Residents N/A
Completed NCT00248807 - A Study of Blood Pressure and Blood Supply to the Brain in Persons With a Spinal Cord Injury. N/A
Terminated NCT00137319 - Impedance Threshold Device Tilt Study N/A
Completed NCT05233865 - Hemodynamic Effects During Land vs Water Exercise for Older Adults With Orthostatic Hypotension N/A
Suspended NCT01370512 - Droxidopa / Pyridostigmine in Orthostatic Hypotension Phase 2
Recruiting NCT00452712 - Orthostatic Hypotension in Children With Acute Febrile Illness Phase 2